BIOEMTECH
BIOEMTECH’s mission and passion is accelerating preclinical research of promising drugs, towards clinical translation, through high quality services and products. BIOEMTECH offers boutique laboratories for evaluating new compounds in all stages of preclinical testing and has developed the “eyes” desktop cameras for real-time in vivo imaging of radionuclides and dyes. The “eyes” also allow for in vivo imaging of alpha emitters (Pb-212 & Ac-225) in oncological models and short scanning times. Both in BIOEMTECH’s services and products, fast screening applications are a core company value towards accelerating drug development.
